Bevacizumab combinations in 1L MBC
Montero et al Curr Oncol Reports 2012, Sini te al Tumori 2016
Bevacizumab in combination with paclitaxel is indicated for 1L treatment of adult patients with MBC
Bevacizumab in combination with capecitabine is indicated for 1L treatment of adult patients with MBC
in whom treatment with other CT options including taxanes or anthracyclines is not considered
appropriate
•
patients who have received taxane and anthracycline-containing regimens in the adjuvant setting within the last 12 mo should be
excluded from treatment with CAPE+BEVA
